Clarapath has filed a notice of an exempt offering of securities to raise $11,265,620.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Clarapath is raising $11,265,620.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Eric Feinstein played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Clarapath
Clarapath is a medical robotics company automating the laboratory. Our first product is focused on fully automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.
To learn more about Clarapath, visit http://clarapath.com/
Contact:
Eric Feinstein, Chief Executive Officer
914-527-2936
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.